NovoCure (NVCR) Q3 2025 Earnings

24JulConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.61
-0.5
-0.39
-0.28

Details

Expected EPS
-0.384062
Actual EPS
-0.36
Surprise EPS
0.02
Surprise Percent
+6.27%

Description

NovoCure (NVCR) has reported earnings of -0.36 per share for Q3 2025.

0 Comments

Share your thoughts